Graf Akcie MYGN (Myriad Genetics, Inc.). Diskuze k akciím MYGN. Aktuální informace MYGN.

Základní informace o společnosti Myriad Genetics, Inc. (Akcie MYGN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.43B
Hodnota podniku (EV) 2.72B
Tržby 662.3M
EBITDA -83.80
Zisk -97.30
Růst v tržbách Q/Q 103.22 %
Růst v tržbách Y/Y 3.71 %
P/E (Cena vůči ziskům) N/A
Forward P/E N/A
EV/Sales 4.10
EV/EBITDA N/A
EV/EBIT N/A
PEG 1.40
Price/Sales 3.66
P/FCF N/A
Price/Book 2.64
Účetní hodnota na akcii 12.01
Hotovost na akcii 2.85
FCF vůči ceně 0.28 %
Počet zaměstnanců 2,700
Tržba na zaměstnance 245.296k
Profit margin -31.24 %
Operating margin -22.72 %
Gross margin 70.86 %
EBIT margin -20.64 %
EBITDA margin -12.65 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -138.71 %
EPS - Očekávaný růst příští rok -80.00 %
Return on assets -7.00 %
Return on equity -10.91 %
ROIC -14.32 %
ROCE -12.55 %
Dluhy/Equity 0.53
Čistý dluh/EBITDA -4.14
Current ratio 1.99
Quick Ratio 1.92
Volatilita 3.93
Beta 1.65
RSI 45.97
Cílová cena analytiků 17
Známka akcie (dle analytiků) 3.40
Insider ownership N/A %
Institutional ownership N/A %
Počet akcií 78.055M
Procento shortovaných akcií 9.76 %
Short ratio 12.68 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk N/A %
Obchodovaná od 1995
Země United States

Finanční výsledky akcie MYGN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$638.6$851.1$743.7$728.7$740.5$723.1
Cost Of Goods Sold$186.1$201$177.2$171.2$157.3$147.4
Gross Profit$452.5$650.1$566.5$557.5$583.2$575.7
Research And Development Expenses$77.2$85.9$70.8$74.4$70.6$75.5
SG&A Expenses$510.1$555.5$435$439.9$359.2$366
Other Operating Income Or Expenses$2.8$-1.1$61.2$0.8--
Operating Expenses$870.3$843.5$621.8$684.7$587.1$588.9
Operating Income$-231.7$7.6$121.9$44$153.4$134.2
Total Non-Operating Income/Expense$8.4$-7.6$-1.8$-7.8$2.6$0.7
Pre-Tax Income$-223.3-$120.1$36.2$156$134.9
Income Taxes$-23.7$-4.4$-13$19$38.8$54.7
Income After Taxes$-199.6$4.4$133.1$17.2$117.2$80.2
Other Income------
Income From Continuous Operations$-199.6$4.4$133.1$17.2$117.2$80.2
Income From Discontinued Operations------
Net Income$-199.5$4.6$133.3$17.4$117.2$80.2
EBITDA$-159.7$80.6$176.3$92.3$180.2$159.2
EBIT$-231.7$7.6$121.9$44$153.4$134.2
Basic Shares Outstanding747469687071
Shares Outstanding747672697375
Basic EPS$-2.69$0.06$1.92$0.25$1.67$1.12
EPS - Earnings Per Share$-2.69$0.06$1.85$0.25$1.60$1.08
# 2020 2019 2018 2017 2016 2015
Current Ratio2.25652.95933.20551.38714.34994.1281
Long-term Debt / Capital0.19640.17660.00950.1143--
Debt/Equity Ratio0.24440.21440.00960.129--
Gross Margin70.858176.383576.173276.506178.757679.6155
Operating Margin-36.28250.89316.3916.038220.715718.559
EBIT Margin-36.28250.89316.3916.038220.715718.559
EBITDA Margin-25.00789.470123.705812.666424.334922.0163
Pre-Tax Profit Margin-34.9671-16.1494.967821.066918.6558
Net Profit Margin-31.24020.540517.92392.387815.827111.0911
Asset Turnover0.45460.54460.63280.60280.8410.9437
Inventory Turnover Ratio6.39526.40135.16624.05694.10715.8725
Receiveable Turnover8.99446.14077.19947.59857.79478.2452
Days Sales In Receivables40.58159.439650.698548.035546.826544.2684
ROE - Return On Equity-21.73820.404113.7772.239615.666412.113
Return On Tangible Equity1357.816-33.845769.2148-43.434436.028327.4376
ROA - Return On Assets-14.21050.281611.32481.422813.310610.4672
ROI - Return On Investment-17.46890.332713.64571.983615.666412.113
Book Value Per Share12.291814.81513.684111.228110.82639.6096
Operating Cash Flow Per Share-0.2843-0.50840.0661-0.72210.3798-0.5463
Free Cash Flow Per Share-0.3085-0.50490.0382-0.74260.6324-0.6843